Application of 2682-49-7, In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, Application of 2682-49-7, name is Thiazolidin-2-one, introducing its new discovery.
Synthesis and antibacterial studies of some 2-(p-substituted benzylidene)-3-(5-methyl-1,3,4-thiadiazol-2-yl)-thiazolidin-4-ones
A series of 2-(p-substituted benzylidene)-3-(5-methyl-1, 3, 4-thiadiazol-2-yl) thiazolidin-4-ones were synthesized by the reaction of Schiff’s bases of N-(p-substituted benzylidene)-5-methyl-1, 3, 4-thiadiazole-2-amines with thioglycolic acid in 1, 4-dioxane as solvent and studied for their in vitro antibacterial activity. Reaction of N-(psubstituted benzylidene)-5-methyl-1, 3, 4-thiadiazole-2-amines with different p-substituted benzaldehydes yielded the compounds Schiff’s bases of N-(p-substituted benzylidene)-5-methyl-1,3, 4-thiadiazole-2-amines which is further reaction with thioglycollic acid in presence of small amount of zinc chloride in 1,4 dioxane as solvent gave title compounds. These compounds were characterized by spectral analysis. All the synthesized compounds were evaluated for their in vitro for their antibacterial activity against two Gram positive bacterial strains (Bacillus subtilis and Staphylococcus aureus) and two Gram negative bacterial strains (Escherichia coli and Pseudomonas aeruginosa) and their minimum inhibitory concentration (MIC) were determined.
If you’re interested in learning more about Reference of 1198-51-2, below is a message from the blog Manager. Application of 2682-49-7
Reference：
Quinuclidine – Wikipedia,
Quinuclidine | C7H356N | ChemSpider